An agonist of receptors, adrenergic alpha-2 that is used in veterinary medicine for its analgesic and sedative properties. It is the racemate of dexmedetomidine.
Administered intravenously, dexmedetomidine is indicated for the sedation of initially intubated and mechanically ventilated patients during treatment in intensive care settings, and for the sedation of non-intubated patients prior to and/or during surgery and other procedures. It is also available as a buccally- or sublingually-administered dissolvable film for the acute treatment of agitation associated with schizophrenia or bipolar I or II disorder.
Peking University First Hospital, Beijing, Beijing, China
Beijing Jishuitan Hospital, Beijing, Beijing, China
Ruijin Hospital, Shanghai, Shanghai, China
Medical School of Karadeniz Technical University, Department of Anesthesiology, Trabzon, Turkey
2nd Department of Anesthesiology, Attikon University Hospital, Athens, Attiki, Greece
Ain Shams University Hospitals, Cairo, Egypt
Dong-Xin Wang, Beijing, Beijing, China
Walaa Y Elsabeeny, Cairo, Egypt
the Affiliated Hospital of Yangzhou University, Yangzhou University, Yangzhou, Jiangsu, China
Ainshams University Hospitals, Cairo, Egypt
Department of Cardiology, Masaryk Hospital and UJEP, Usti nad Labem, Czech Republic., Ústí Nad Labem, Czechia
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.